Inventor
LI CHIANG JIA
US29 patents
⚠️ This page may combine multiple inventors who share the name “LI CHIANG JIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOSTON BIOMEDICAL INC
11 patentsUS9834532B2Dec 5, 2017
Stat3 pathway inhibitors and cancer stem cell inhibitors
BOSTON BIOMEDICAL INC4 citations83
US10377731B2Aug 13, 2019
Compositions and methods for cancer treatment
BOSTON BIOMEDICAL INC3 citations81
US9795595B2Oct 24, 2017
Methods for treating cancer
BOSTON BIOMEDICAL INC3 citations73
US9381184B2Jul 5, 2016
Compounds and compositions for targeting cancer stem cells
BOSTON BIOMEDICAL INC4 citations72
US9187454B2Nov 17, 2015
Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
BOSTON BIOMEDICAL INC4 citations68
US10646464B2May 12, 2020
Methods for treating cancer
BOSTON BIOMEDICAL INC1 citations60
US10934309B2Mar 2, 2021
Tricyclic quinone derivative
BOSTON BIOMEDICAL INC1 citations58
US10543189B2Jan 28, 2020
2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
BOSTON BIOMEDICAL INC1 citations57
US9725444B2Aug 8, 2017
Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
BOSTON BIOMEDICAL INC0 citations51
US10800752B2Oct 13, 2020
Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
BOSTON BIOMEDICAL INC0 citations50
US10183925B2Jan 22, 2019
Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
BOSTON BIOMEDICAL INC0 citations50
LI CHIANG JIA
6 patentsUS9328345B2May 3, 2016
Compositions of asymmetric interfering RNA and uses thereof
LI CHIANG JIA42 citations96
US9745278B2Aug 29, 2017
Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors
LI CHIANG JIA7 citations83
US9084766B2Jul 21, 2015
Compounds and compositions for targeting cancer stem cells
LI CHIANG JIA7 citations83
US8299106B2Oct 30, 2012
Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
LI CHIANG JIA12 citations82
US9732055B2Aug 15, 2017
Compositions and methods for cancer treatment
LI CHIANG JIA8 citations81
US9730909B2Aug 15, 2017
Methods for targeting cancer stem cells
LI CHIANG JIA4 citations72
1GLOBE HEALTH INST LLC
4 patentsUS11015195B2May 25, 2021
Compositions of asymmetric interfering RNA and uses thereof
1GLOBE HEALTH INST LLC2 citations70
US10927376B2Feb 23, 2021
Compositions of asymmetric interfering RNA and uses thereof
1GLOBE HEALTH INST LLC3 citations70
US12344840B2Jul 1, 2025
Compositions of asymmetric interfering RNA and uses thereof
1GLOBE HEALTH INST LLC0 citations60
US11001840B2May 11, 2021
Biodegradable and clinically-compatible nanoparticles as drug delivery carriers
1GLOBE HEALTH INST LLC1 citations52
SUMITOMO DAINIPPON PHARMA CO LTD
3 patentsUS9248173B2Feb 2, 2016
WT1 antigen peptide conjugate vaccine
SUMITOMO DAINIPPON PHARMA CO LTD14 citations92
US9181302B2Nov 10, 2015
WT1 antigen peptide conjugate vaccine
SUMITOMO DAINIPPON PHARMA CO LTD17 citations92
US10898469B2Jan 26, 2021
Imidazolylamide derivative
SUMITOMO DAINIPPON PHARMA CO LTD0 citations44